> top > docs > PMC:7127009 > annotations

PMC:7127009 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 20-41 Disease denotes coronavirus infection MESH:D018352
3 45-63 Disease denotes rheumatic diseases MESH:D012216
31 1232-1236 Gene denotes IL-1 Gene:3552
32 1246-1250 Gene denotes IL-6 Gene:3569
33 1472-1477 Gene denotes CD200 Gene:4345
34 108-119 Species denotes Coronavirus Tax:11118
35 233-249 Species denotes beta-coronavirus Tax:694002
36 257-266 Species denotes SARS-CoV2 Tax:2697049
37 301-309 Species denotes MERS-CoV Tax:1335626
38 371-380 Species denotes SARS-CoV2 Tax:2697049
39 595-603 Species denotes patients Tax:9606
40 1557-1565 Species denotes patients Tax:9606
41 1836-1844 Species denotes patients Tax:9606
42 1316-1327 Chemical denotes tocilizumab MESH:C502936
43 1371-1382 Chemical denotes Baricitinib MESH:C000596027
44 184-192 Disease denotes CoViD-19 MESH:C000657245
45 415-425 Disease denotes infections MESH:D007239
46 485-505 Disease denotes respiratory symptoms MESH:D012818
47 523-558 Disease denotes acute respiratory distress syndrome MESH:D012128
48 657-679 Disease denotes coronavirus infections MESH:D018352
49 899-907 Disease denotes CoViD-19 MESH:C000657245
50 939-948 Disease denotes rheumatic MESH:D012216
51 1216-1225 Disease denotes infection MESH:D007239
52 1529-1537 Disease denotes CoViD-19 MESH:C000657245
53 1539-1556 Disease denotes Rheumatic disease MESH:D012216
54 1660-1669 Disease denotes infection MESH:D007239
55 1740-1749 Disease denotes infection MESH:D007239
56 1826-1835 Disease denotes rheumatic MESH:D012216
57 1850-1858 Disease denotes CoViD-19 MESH:C000657245
61 1908-1917 Species denotes SARS-CoV2 Tax:2697049
62 1875-1883 Disease denotes CoViD-19 MESH:C000657245
63 1936-1971 Disease denotes acute respiratory distress syndrome MESH:D012128
67 2001-2005 Gene denotes IL-1 Gene:3552
68 2015-2019 Gene denotes IL-6 Gene:3569
69 2088-2096 Disease denotes CoViD-19 MESH:C000657245
73 2139-2147 Species denotes patients Tax:9606
74 2121-2138 Disease denotes rheumatic disease MESH:D012216
75 2174-2183 Disease denotes infection MESH:D007239
78 2216-2224 Species denotes Patients Tax:9606
79 2296-2305 Disease denotes infection MESH:D007239
82 2311-2320 Species denotes SARS-CoV2 Tax:2697049
83 2329-2364 Disease denotes acute respiratory distress syndrome MESH:D012128
123 2475-2491 Species denotes beta-Coronavirus Tax:694002
124 3119-3127 Species denotes patients Tax:9606
125 3347-3355 Species denotes patients Tax:9606
126 3677-3685 Species denotes patients Tax:9606
127 3989-3997 Species denotes patients Tax:9606
128 4181-4190 Species denotes SARS-CoV2 Tax:2697049
129 4327-4340 Species denotes Coronaviridae Tax:11118
130 4458-4463 Species denotes human Tax:9606
131 4503-4512 Species denotes SARS-CoV2 Tax:2697049
132 4562-4577 Species denotes betacoronavirus Tax:694002
133 4608-4611 Species denotes CoV Tax:11118
134 4690-4699 Species denotes SARS-CoV2 Tax:2697049
135 4944-4953 Species denotes SARS-CoV2 Tax:2697049
136 4998-5014 Species denotes SARS Coronavirus Tax:694009
137 5016-5024 Species denotes SARS-CoV Tax:694009
138 5118-5127 Species denotes MERS)-CoV Tax:1335626
139 5264-5269 Species denotes camel Tax:9837
140 5290-5296 Species denotes humans Tax:9606
141 2534-2544 Species denotes SARS)-CoV2 Tax:2697049
142 3606-3617 Chemical denotes tocilizumab MESH:C502936
143 2365-2389 Disease denotes Coronavirus Disease-2019 MESH:C000657245
144 2391-2399 Disease denotes CoViD-19 MESH:C000657245
145 2499-2532 Disease denotes Severe Acute Respiratory Syndrome MESH:D045169
146 2643-2651 Disease denotes CoViD-19 MESH:C000657245
147 2745-2764 Disease denotes respiratory illness MESH:D012140
148 2823-2832 Disease denotes infection MESH:D007239
149 2899-2908 Disease denotes infection MESH:D007239
150 2964-2972 Disease denotes infected MESH:D007239
151 3031-3039 Disease denotes CoViD-19 MESH:C000657245
152 3070-3078 Disease denotes CoViD-19 MESH:C000657245
153 3133-3151 Disease denotes rheumatic diseases MESH:D012216
154 3300-3314 Disease denotes severe disease MESH:D045169
155 3318-3326 Disease denotes infected MESH:D007239
156 3332-3340 Disease denotes CoViD-19 MESH:C000657245
157 3825-3833 Disease denotes CoViD-19 MESH:C000657245
158 3834-3843 Disease denotes infection MESH:D007239
159 3971-3988 Disease denotes rheumatic disease MESH:D012216
160 5084-5116 Disease denotes Middle East Respiratory Syndrome MESH:D018352
161 5144-5154 Disease denotes infections MESH:D007239
166 5392-5401 Species denotes SARS-CoV Tax:2697049
167 5517-5525 Species denotes patient Tax:9606
168 5402-5411 Disease denotes infectio MESH:D007239
169 5605-5614 Disease denotes mortalit MESH:D003643
187 5657-5665 Species denotes patient Tax:9606
188 5765-5773 Species denotes patient Tax:9606
189 6143-6151 Species denotes patient Tax:9606
190 6323-6332 Species denotes SARS-CoV Tax:2697049
191 5620-5628 Disease denotes CoViD-1 MESH:C000657245
192 5629-5638 Disease denotes infectio MESH:D007239
193 5674-5679 Disease denotes feve MESH:D005334
194 5681-5686 Disease denotes coug MESH:D003371
195 5688-5695 Disease denotes myalgi MESH:D063806
196 5700-5707 Disease denotes fatigu MESH:D005221
197 5737-5746 Disease denotes pneumoni MESH:D011014
198 5951-5970 Disease denotes respiratory failur MESH:D012131
199 5974-6009 Disease denotes acute respiratory distress syndrom MESH:D012128
200 6011-6015 Disease denotes (ARD MESH:D012128
201 6078-6087 Disease denotes mortalit MESH:D003643
202 6176-6192 Disease denotes chronic disease MESH:D002908
203 6333-6342 Disease denotes infectio MESH:D007239
208 6582-6585 Gene denotes -IL Gene:3569
209 6592-6595 Gene denotes -IL Gene:3552
210 6600-6611 Chemical denotes baricitini MESH:C000596027
211 6523-6532 Disease denotes -rheumati MESH:D012216
217 8950-8954 Gene denotes AAK Gene:22848
218 8957-8988 Gene denotes  AP2-associated protein kinase Gene:22848
219 8908-8917 Disease denotes -rheumati MESH:D012216
220 8927-8948 Disease denotes coronavirus infectio MESH:D018352
221 8997-9030 Disease denotes  severe acute respiratory syndrom MESH:D045169
250 7368-7373 Gene denotes spik Gene:43740568
251 7062-7067 Gene denotes “spik Gene:43740568
252 6818-6826 Species denotes patient Tax:9606
253 6979-6988 Species denotes SARS-CoV Tax:2697049
254 6993-7001 Species denotes SARS-Co Tax:694009
255 7007-7020 Species denotes coronaviruse Tax:11118
256 7670-7678 Species denotes patient Tax:9606
257 8457-8465 Species denotes patient Tax:9606
258 8544-8552 Species denotes patient Tax:9606
259 8672-8680 Species denotes patient Tax:9606
260 7529-7540 Chemical denotes chloroquin MESH:D002738
261 7776-7794 Chemical denotes hydroxychloroquin MESH:D006886
262 7841-7852 Chemical denotes chloroquin MESH:D002738
263 7992-8003 Chemical denotes chloroquin MESH:D002738
264 8186-8197 Chemical denotes chloroquin MESH:D002738
265 8411-8422 Chemical denotes chloroquin MESH:D002738
266 8426-8444 Chemical denotes hydroxychloroquin MESH:D006886
267 8467-8485 Chemical denotes Hydroxychloroquin MESH:D006886
268 6751-6759 Disease denotes CoViD-1 MESH:C000657245
269 6760-6769 Disease denotes infectio MESH:D007239
270 6857-6865 Disease denotes CoViD-1 MESH:C000657245
271 7652-7660 Disease denotes CoViD-1 MESH:C000657245
272 7661-7669 Disease denotes infecte MESH:D007239
273 8277-8285 Disease denotes CoViD-1 MESH:C000657245
274 8304-8312 Disease denotes toxicit MESH:D064420
275 8448-8456 Disease denotes CoViD-1 MESH:C000657245
276 8535-8543 Disease denotes CoViD-1 MESH:C000657245
277 8662-8671 Disease denotes rheumati MESH:D012216
309 10011-10029 Gene denotes interleukin (IL)- Gene:3552
310 10031-10035 Gene denotes IL- Gene:3569
311 10286-10290 Gene denotes IL- Gene:3569
312 11155-11159 Gene denotes -IL- Gene:3569
313 9063-9068 Species denotes huma Tax:9606
314 9078-9086 Species denotes patient Tax:9606
315 9169-9177 Species denotes Patient Tax:9606
316 9519-9524 Species denotes huma Tax:9606
317 10121-10129 Species denotes patient Tax:9606
318 10897-10905 Species denotes patient Tax:9606
319 11078-11086 Species denotes patient Tax:9606
320 10422-10433 Chemical denotes Tocilizuma MESH:C502936
321 10870-10881 Chemical denotes tocilizuma MESH:C502936
322 9036-9059 Disease denotes pulmonary complication MESH:D008171
323 9069-9077 Disease denotes CoViD-1 MESH:C000657245
324 9152-9167 Disease denotes alveolar damag MESH:D055370
325 9225-9230 Disease denotes edem MESH:D004487
326 9336-9351 Disease denotes alveolar damag MESH:D055370
327 9553-9557 Disease denotes MER MESH:D018352
328 9558-9567 Disease denotes infectio MESH:D007239
329 9641-9657 Disease denotes viral infection MESH:D001102
330 9727-9754 Disease denotes MERS coronavirus infection MESH:D018352
331 10176-10180 Disease denotes MER MESH:D018352
332 10181-10190 Disease denotes infectio MESH:D007239
333 10505-10525 Disease denotes rheumatoid arthriti MESH:D001172
334 10536-10555 Disease denotes autoimmune disease MESH:D001327
335 10937-10957 Disease denotes respiratory syndrom MESH:D012120
336 10965-10973 Disease denotes CoViD-1 MESH:C000657245
337 10974-10983 Disease denotes infectio MESH:D007239
338 11208-11237 Disease denotes respiratory distress syndrom MESH:D012128
339 11241-11249 Disease denotes CoViD-1 MESH:C000657245
367 11277-11280 Gene denotes -IL Gene:3552
368 11352-11357 Gene denotes NLRP Gene:114548
369 11402-11407 Gene denotes IL-1 Gene:3552
370 11567-11572 Gene denotes IL-1 Gene:3552
371 11776-11803 Gene denotes Janus Kinases (JAK) 1 and Gene:3716
372 12200-12231 Gene denotes AP2-associated protein kinase Gene:22848
373 12233-12237 Gene denotes (AAK Gene:22848
374 12274-12278 Gene denotes AAK Gene:22848
375 12294-12298 Gene denotes AAK Gene:22848
376 12614-12618 Gene denotes AAK Gene:22848
377 12011-12016 Gene denotes spik Gene:43740568
378 11374-11382 Species denotes SARS-Co Tax:694009
379 11479-11488 Species denotes SARS-CoV Tax:2697049
380 11537-11545 Species denotes patient Tax:9606
381 11628-11637 Species denotes SARS-CoV Tax:2697049
382 11736-11744 Species denotes patient Tax:9606
383 11966-11975 Species denotes SARS-CoV Tax:2697049
384 12719-12727 Species denotes patient Tax:9606
385 11883-11886 Gene denotes IF Gene:3439
386 11675-11686 Chemical denotes baricitini MESH:C000596027
387 12240-12251 Chemical denotes Baricitini MESH:C000596027
388 12513-12524 Chemical denotes baricitini MESH:C000596027
389 11489-11498 Disease denotes infectio MESH:D007239
390 11652-11671 Disease denotes respiratory diseas MESH:D012140
391 11715-11735 Disease denotes rheumatoid arthriti MESH:D001172
392 12679-12691 Disease denotes inflammatio MESH:D007249
393 12710-12718 Disease denotes CoViD-1 MESH:C000657245
421 13230-13233 Gene denotes IF Gene:3439
422 14013-14018 Gene denotes IFN- Gene:111654
423 14281-14284 Gene denotes IF Gene:3439
424 14439-14442 Gene denotes IF Gene:3439
425 13546-13549 Gene denotes IF Gene:3439
426 13210-13213 Gene denotes IF Gene:3439
427 12833-12836 Gene denotes IF Gene:3439
428 12774-12782 Species denotes patient Tax:9606
429 13152-13157 Species denotes mous Tax:10090
430 13182-13193 Species denotes coronaviru Tax:11118
431 13447-13452 Species denotes huma Tax:9606
432 13587-13592 Species denotes huma Tax:9606
433 13619-13624 Species denotes mous Tax:10090
434 14026-14031 Species denotes mous Tax:10090
435 14219-14227 Species denotes patient Tax:9606
436 14670-14679 Species denotes SARS-CoV Tax:2697049
437 14663-14666 Gene denotes IF Gene:3439
438 13920-13923 Gene denotes IF Gene:3439
439 13847-13858 Chemical denotes baricitini MESH:C000596027
440 12757-12765 Disease denotes CoViD-1 MESH:C000657245
441 12993-13001 Disease denotes infecte MESH:D007239
442 13323-13332 Disease denotes mortalit MESH:D003643
443 13345-13357 Disease denotes lung diseas MESH:D008171
444 13453-13472 Disease denotes SARS-CoV infection MESH:C000657245
445 13593-13605 Disease denotes lung diseas MESH:D008171
446 14053-14065 Disease denotes lung diseas MESH:D008171
447 14397-14409 Disease denotes lung diseas MESH:D008171
470 14998-15003 Gene denotes CD20 Gene:4345
471 15004-15011 Gene denotes -CD200R Gene:131450
472 15214-15218 Gene denotes TLR Gene:170743
473 15413-15418 Gene denotes CD20 Gene:4345
474 15419-15426 Gene denotes -CD200R Gene:131450
475 15495-15498 Gene denotes IF Gene:3439
476 15802-15807 Gene denotes CD20 Gene:4345
477 15930-15935 Gene denotes CD20 Gene:4345
478 15289-15294 Species denotes mous Tax:10090
479 15687-15692 Species denotes huma Tax:9606
480 15768-15774 Species denotes murin Tax:10090
481 15973-15978 Species denotes huma Tax:9606
482 16196-16204 Species denotes patient Tax:9606
483 14883-14889 Disease denotes cance MESH:D009369
484 15304-15325 Disease denotes coronavirus infectio MESH:D018352
485 15451-15472 Disease denotes coronavirus infectio MESH:D018352
486 15638-15645 Disease denotes cancer MESH:D009369
487 15693-15712 Disease denotes infectious disease MESH:D003141
488 15784-15798 Disease denotes LCMV infectio MESH:D007239
489 15979-15985 Disease denotes cance MESH:D009369
490 16105-16113 Disease denotes CoViD-1 MESH:C000657245
491 16187-16195 Disease denotes CoViD-1 MESH:C000657245
495 16234-16242 Species denotes patient Tax:9606
496 16224-16233 Disease denotes rheumati MESH:D012216
497 16254-16262 Disease denotes CoViD-1 MESH:C000657245
512 18455-18464 Species denotes SARS-CoV Tax:2697049
513 18574-18582 Species denotes patient Tax:9606
514 18643-18651 Species denotes patient Tax:9606
515 18903-18909 Species denotes peopl Tax:9606
516 18975-18983 Species denotes patient Tax:9606
517 18387-18401 Chemical denotes 3- Chloroquin
518 18406-18424 Chemical denotes hydroxychloroquin MESH:D006886
519 18598-18609 Chemical denotes tocilizuma MESH:C502936
520 18614-18625 Chemical denotes baricitini MESH:C000596027
521 18243-18252 Disease denotes infectio MESH:D007239
522 18465-18474 Disease denotes infectio MESH:D007239
523 18564-18573 Disease denotes rheumati MESH:D012216
524 18726-18734 Disease denotes CoViD-1 MESH:C000657245
525 18742-18751 Disease denotes pneumoni MESH:D011014
528 18114-18132 Disease denotes rheumatic disease MESH:D012216
529 18140-18148 Disease denotes CoViD-1 MESH:C000657245
552 16299-16308 Species denotes SARS-CoV Tax:2697049
553 16375-16388 Species denotes coronaviruse Tax:11118
554 16661-16669 Species denotes SARS-Co Tax:694009
555 16674-16683 Species denotes SARS-CoV Tax:2697049
556 16836-16844 Species denotes patient Tax:9606
557 17222-17230 Species denotes patient Tax:9606
558 17311-17319 Species denotes patient Tax:9606
559 17430-17438 Species denotes patient Tax:9606
560 17646-17654 Species denotes patient Tax:9606
561 17819-17826 Species denotes patien Tax:9606
562 16787-16796 Disease denotes infectio MESH:D007239
563 16827-16835 Disease denotes infecte MESH:D007239
564 17213-17221 Disease denotes CoViD-1 MESH:C000657245
565 17274-17283 Disease denotes infectio MESH:D007239
566 17301-17310 Disease denotes rheumati MESH:D012216
567 17420-17429 Disease denotes rheumati MESH:D012216
568 17520-17537 Disease denotes rheumatic diseas MESH:D012216
569 17675-17683 Disease denotes CoViD-1 MESH:C000657245
570 17886-17895 Disease denotes infectio MESH:D007239
571 17904-17922 Disease denotes rheumatic disease MESH:D012216
572 17931-17951 Disease denotes rheumatoid arthriti MESH:D001172
573 18061-18070 Disease denotes infectio MESH:D007239
603 20571-20575 Gene denotes IL- Gene:3569
604 19110-19118 Species denotes patient Tax:9606
605 19427-19435 Species denotes patient Tax:9606
606 19476-19484 Species denotes Patient Tax:9606
607 19618-19626 Species denotes patient Tax:9606
608 19689-19699 Species denotes outpatien Tax:9606
609 19765-19771 Species denotes peopl Tax:9606
610 20071-20079 Species denotes patient Tax:9606
611 20126-20133 Species denotes patien Tax:9606
612 20473-20481 Species denotes patient Tax:9606
613 20822-20831 Species denotes SARS-CoV Tax:2697049
614 20957-20965 Species denotes patient Tax:9606
615 19911-19922 Chemical denotes tocilizuma MESH:C502936
616 19927-19938 Chemical denotes baricitini MESH:C000596027
617 20354-20372 Chemical denotes hydroxychloroquin MESH:D006886
618 19100-19109 Disease denotes rheumati MESH:D012216
619 19417-19426 Disease denotes rheumati MESH:D012216
620 19608-19617 Disease denotes rheumati MESH:D012216
621 19650-19658 Disease denotes CoViD-1 MESH:C000657245
622 19969-19977 Disease denotes CoViD-1 MESH:C000657245
623 19985-19994 Disease denotes pneumoni MESH:D011014
624 20061-20070 Disease denotes rheumati MESH:D012216
625 20116-20125 Disease denotes rheumati MESH:D012216
626 20159-20168 Disease denotes infectio MESH:D007239
627 20322-20331 Disease denotes infectio MESH:D007239
628 20415-20423 Disease denotes CoViD-1 MESH:C000657245
629 20424-20433 Disease denotes infectio MESH:D007239
630 20512-20529 Disease denotes rheumatic diseas MESH:D012216
631 20655-20667 Disease denotes lung diseas MESH:D008171
641 21573-21581 Species denotes patient Tax:9606
642 21079-21088 Disease denotes infectio MESH:D007239
643 21108-21116 Disease denotes CoViD-1 MESH:C000657245
644 21249-21258 Disease denotes infectio MESH:D007239
645 21271-21289 Disease denotes rheumatic disease MESH:D012216
646 21563-21572 Disease denotes rheumati MESH:D012216
647 21609-21617 Disease denotes CoViD-1 MESH:C000657245
648 21618-21627 Disease denotes infectio MESH:D007239
649 21738-21748 Disease denotes Rheumatis MESH:D012216
652 21850-21858 Species denotes patient Tax:9606
653 21987-21996 Disease denotes infectio MESH:D007239

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 562-570 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T2 1104-1113 Body_part denotes lysosomal http://purl.org/sig/ont/fma/fma63836
T3 1163-1167 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T4 1232-1236 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T5 1232-1234 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T6 1246-1248 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T7 1274-1282 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T8 2001-2005 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T9 2001-2003 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T10 2015-2017 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T11 2062-2070 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T12 3744-3752 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T13 3798-3806 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T14 4226-4236 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T15 4237-4240 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T16 4299-4307 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T17 4973-4977 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T18 5546-5559 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T19 5864-5869 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T20 6593-6596 Body_part denotes IL1 http://purl.org/sig/ont/fma/fma86583
T21 7040-7052 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T22 7221-7225 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T23 7226-7242 Body_part denotes epithelial cells http://purl.org/sig/ont/fma/fma66768
T24 7237-7242 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T25 7244-7255 Body_part denotes enterocytes http://purl.org/sig/ont/fma/fma62122
T26 7257-7263 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T27 7281-7286 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T28 7291-7308 Body_part denotes endothelial cells http://purl.org/sig/ont/fma/fma66772
T29 7303-7308 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T30 7338-7347 Body_part denotes lysosomal http://purl.org/sig/ont/fma/fma63836
T31 7375-7382 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T32 7450-7454 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T33 7925-7942 Body_part denotes connective tissue http://purl.org/sig/ont/fma/fma9640
T34 8973-8980 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T35 9153-9161 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T36 9206-9210 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T37 9265-9279 Body_part denotes bronchial tree http://purl.org/sig/ont/fma/fma26660
T38 9337-9345 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T39 9393-9404 Body_part denotes neutrophils http://purl.org/sig/ont/fma/fma62860
T40 9409-9420 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T41 9454-9466 Body_part denotes interstitium http://purl.org/sig/ont/fma/fma86301
T42 9570-9579 Body_part denotes Cytokines http://purl.org/sig/ont/fma/fma84050
T43 9584-9594 Body_part denotes chemokines http://purl.org/sig/ont/fma/fma241981
T44 9844-9853 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T45 9944-9953 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T46 9954-9964 Body_part denotes chemokines http://purl.org/sig/ont/fma/fma241981
T47 10012-10023 Body_part denotes interleukin http://purl.org/sig/ont/fma/fma86578
T48 10024-10030 Body_part denotes (IL)-1 http://purl.org/sig/ont/fma/fma86583
T49 10025-10027 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T50 10032-10034 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T51 10064-10073 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T52 10250-10256 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T53 10267-10276 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T54 10287-10289 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T55 10398-10406 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T56 10444-10446 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T57 10458-10466 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T58 10751-10755 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T59 10822-10830 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T60 11102-11106 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T61 11156-11158 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T62 11278-11281 Body_part denotes IL1 http://purl.org/sig/ont/fma/fma86583
T63 11403-11407 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T64 11403-11405 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T65 11528-11533 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T66 11562-11567 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T67 11568-11572 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T68 11568-11570 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T69 11987-11994 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T70 12057-12062 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T71 12216-12223 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T72 12490-12496 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T73 12942-12953 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T74 12958-12973 Body_part denotes dendritic cells http://purl.org/sig/ont/fma/fma273565
T75 12968-12973 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T76 13007-13027 Body_part denotes natural killer cells http://purl.org/sig/ont/fma/fma63147
T77 13022-13027 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T78 13346-13350 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T79 13402-13413 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T80 13423-13427 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T81 13594-13598 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T82 13718-13722 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T83 14054-14058 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T84 14398-14402 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T85 14624-14628 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T86 14825-14838 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T87 14891-14896 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T88 15235-15238 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T89 15269-15284 Body_part denotes dendritic cells http://purl.org/sig/ont/fma/fma273565
T90 15279-15284 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T91 15353-15363 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T92 15819-15826 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T93 15909-15917 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T94 20572-20574 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578
T95 20656-20660 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T96 20840-20844 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 5546-5559 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T2 5864-5869 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T3 7221-7225 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T4 7257-7263 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T5 7925-7942 Body_part denotes connective tissue http://purl.obolibrary.org/obo/UBERON_0002384
T6 7936-7942 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T7 9206-9210 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T8 11102-11106 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T9 11562-11567 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T10 13346-13350 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T11 13423-13427 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T12 13594-13598 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T13 13718-13722 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T14 14054-14058 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T15 14398-14402 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T16 14624-14628 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T17 14825-14838 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T18 20656-20660 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T19 20840-20844 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid_AGAC

Id Subject Object Predicate Lexical cue
p84658s4 14272-14281 NegReg denotes decreased
p84658s5 14282-14285 MPA denotes IFN
p84658s35 14444-14461 Pathway denotes signaling pathway
p84668s22 15486-15495 PosReg denotes restoring
p84668s23 15496-15510 MPA denotes IFN production
p84668s26 15515-15525 PosReg denotes increasing

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 32-41 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T2 45-63 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T3 184-192 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 257-261 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T5 292-296 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T6 371-375 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T7 415-425 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T8 523-558 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T9 529-558 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T10 669-679 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T11 899-907 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1216-1225 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T13 1529-1537 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T14 1539-1556 Disease denotes Rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T15 1660-1669 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T16 1740-1749 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T17 1850-1858 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 1875-1883 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T19 1908-1912 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T20 1936-1971 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T21 1942-1971 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T22 2088-2096 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 2121-2138 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T24 2174-2183 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T25 2296-2305 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T26 2311-2315 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T27 2329-2364 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T28 2335-2364 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T29 2365-2389 Disease denotes Coronavirus Disease-2019 http://purl.obolibrary.org/obo/MONDO_0100096
T30 2391-2399 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T31 2499-2532 Disease denotes Severe Acute Respiratory Syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T32 2534-2538 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T33 2643-2651 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T34 2823-2832 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T35 2899-2908 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T36 3031-3039 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T37 3070-3078 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T38 3133-3151 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T39 3332-3340 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T40 3771-3774 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T42 3825-3833 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T43 3834-3843 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T44 3971-3988 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T45 4181-4185 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T46 4503-4507 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T47 4690-4694 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T48 4944-4948 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T49 4998-5002 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T50 5016-5024 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T51 5016-5020 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T52 5144-5157 Disease denotes infections in http://purl.obolibrary.org/obo/MONDO_0005550
T53 5393-5397 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T54 5403-5412 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T55 5621-5629 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T56 5630-5639 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T57 5738-5747 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T58 5952-5971 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T59 5975-6010 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T60 5981-6010 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T61 6012-6016 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T62 6324-6328 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T63 6334-6343 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T64 6752-6760 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T65 6761-6770 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T66 6858-6866 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T67 6980-6984 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T68 6994-7002 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T69 6994-6998 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T70 7653-7661 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T71 7925-7950 Disease denotes connective tissue disease http://purl.obolibrary.org/obo/MONDO_0003900|http://purl.obolibrary.org/obo/MONDO_0005554
T73 8278-8286 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T74 8449-8457 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T75 8536-8544 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T76 8940-8949 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T77 8991-8995 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T78 8998-9031 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T79 9070-9078 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T80 9196-9200 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T81 9559-9568 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T82 9642-9658 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T83 9719-9723 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T84 9745-9755 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T85 10169-10173 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T86 10182-10191 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T87 10418-10421 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T89 10506-10526 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T90 10517-10526 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T91 10537-10556 Disease denotes autoimmune diseases http://purl.obolibrary.org/obo/MONDO_0007179
T92 10648-10651 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T94 10966-10974 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T95 10975-10984 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T96 11209-11238 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T97 11242-11250 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T98 11375-11383 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T99 11375-11379 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T100 11480-11484 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T101 11490-11499 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T102 11629-11633 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T103 11653-11672 Disease denotes respiratory disease http://purl.obolibrary.org/obo/MONDO_0005087
T104 11716-11736 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T105 11727-11736 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T106 11967-11971 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T107 12680-12692 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T108 12711-12719 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T109 12758-12766 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T110 12936-12940 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T111 13346-13358 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T112 13454-13462 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T113 13454-13458 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T114 13463-13473 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T115 13594-13606 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T116 14054-14066 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T117 14398-14410 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T118 14671-14675 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T119 14884-14890 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T120 15317-15326 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T121 15464-15473 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T122 15694-15704 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T123 15790-15799 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T124 15980-15986 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T125 16106-16114 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T126 16188-16196 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T127 16255-16263 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T128 16300-16304 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T129 16662-16670 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T130 16662-16666 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T131 16675-16679 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T132 16788-16797 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T133 17214-17222 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T134 17275-17284 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T135 17521-17538 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T136 17676-17684 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T137 17887-17896 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T138 17905-17923 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T139 17932-17952 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T140 17943-17952 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T141 18062-18071 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T142 18115-18133 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T143 18141-18149 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T144 18244-18253 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T145 18456-18460 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T146 18466-18475 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T147 18727-18735 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T148 18743-18752 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T149 19292-19306 Disease denotes adrenal crisis http://purl.obolibrary.org/obo/MONDO_0019801
T150 19651-19659 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T151 19970-19978 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T152 19986-19995 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T153 20160-20169 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T154 20323-20332 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T155 20416-20424 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T156 20425-20434 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T157 20513-20530 Disease denotes rheumatic disease http://purl.obolibrary.org/obo/MONDO_0005554
T158 20656-20668 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T159 20823-20827 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T160 20902-20905 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T162 21080-21089 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T163 21109-21117 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T164 21250-21259 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T165 21272-21290 Disease denotes rheumatic diseases http://purl.obolibrary.org/obo/MONDO_0005554
T166 21610-21618 Disease denotes CoViD-19 http://purl.obolibrary.org/obo/MONDO_0100096
T167 21619-21628 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T168 21739-21749 Disease denotes Rheumatism http://purl.obolibrary.org/obo/MONDO_0005554
T169 21988-21997 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 198-199 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 219-220 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 221-224 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bat
T4 560-561 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T5 577-580 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T6 786-787 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 909-910 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T8 1104-1113 http://purl.obolibrary.org/obo/GO_0005764 denotes lysosomal
T9 1163-1167 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T10 1328-1331 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T11 1355-1356 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T12 1383-1386 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T13 1502-1503 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T14 1887-1888 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T15 2401-2404 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T16 2437-2438 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T17 2467-2468 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18 2672-2684 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T19 2833-2836 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T20 2877-2878 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 3040-3041 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T22 3088-3091 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T23 3183-3184 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 3698-3699 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T25 4027-4032 http://purl.obolibrary.org/obo/UBERON_0007688 denotes field
T26 4194-4195 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T27 4241-4246 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T28 4296-4298 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T29 4407-4408 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T30 4409-4412 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bat
T31 4458-4463 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T32 4520-4521 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T33 4560-4561 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T34 4592-4596 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bats
T35 4662-4668 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bat is
T36 4725-4731 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T37 4768-4771 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T38 4865-4866 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T39 4883-4887 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bats
T40 4902-4906 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bats
T41 4973-4977 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T42 5205-5212 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T43 5264-5269 http://purl.obolibrary.org/obo/NCBITaxon_9837 denotes camel
T44 5290-5296 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T45 5360-5363 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T46 5532-5533 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T47 5546-5559 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T48 5567-5568 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T49 5864-5869 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T50 6077-6078 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T51 6256-6262 http://purl.obolibrary.org/obo/CLO_0001302 denotes 3], [4
T52 6426-6432 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T53 6464-6468 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T54 6654-6659 http://purl.obolibrary.org/obo/UBERON_0007688 denotes field
T55 6914-6915 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T56 7030-7031 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T57 7060-7061 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T58 7123-7126 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T59 7221-7242 http://purl.obolibrary.org/obo/CL_0000082 denotes lung epithelial cells
T60 7257-7263 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T61 7257-7263 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T62 7257-7263 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T63 7281-7286 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T64 7291-7308 http://purl.obolibrary.org/obo/CL_0000115 denotes endothelial cells
T65 7338-7347 http://purl.obolibrary.org/obo/GO_0005764 denotes lysosomal
T66 7397-7403 http://purl.obolibrary.org/obo/SO_0000418 denotes signal
T67 7404-7411 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T68 7450-7454 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T69 7858-7861 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T70 7862-7863 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T71 7925-7942 http://purl.obolibrary.org/obo/UBERON_0002384 denotes connective tissue
T72 7925-7942 http://www.ebi.ac.uk/efo/EFO_0000952 denotes connective tissue
T73 7952-7955 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T74 7956-7957 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T75 8081-8082 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T76 8216-8217 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T77 9064-9069 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T78 9206-9210 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T79 9206-9210 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T80 9362-9370 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T81 9454-9466 http://purl.obolibrary.org/obo/UBERON_0005169 denotes interstitium
T82 9520-9525 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T83 9600-9601 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T84 9689-9692 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T85 10250-10256 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T86 10355-10356 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T87 10472-10475 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T88 10558-10561 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T89 10602-10603 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90 10749-10755 http://purl.obolibrary.org/obo/CL_0000084 denotes T-cell
T91 10757-10760 http://purl.obolibrary.org/obo/CLO_0002199 denotes CAR
T92 10854-10855 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T93 11060-11061 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T94 11102-11106 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T95 11102-11106 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T96 11170-11171 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T97 11252-11253 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T98 11335-11345 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T99 11454-11464 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T100 11528-11533 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T101 11764-11765 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T102 11844-11853 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T103 11888-11897 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T104 11951-11958 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T105 11985-11986 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T106 12057-12062 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T107 12071-12072 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T108 12181-12182 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T109 12253-12256 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T110 12399-12404 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T111 12464-12469 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T112 12490-12496 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T113 12809-12810 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T114 12958-12973 http://purl.obolibrary.org/obo/CL_0000451 denotes dendritic cells
T115 13007-13027 http://purl.obolibrary.org/obo/CL_0000623 denotes natural killer cells
T116 13036-13045 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T117 13053-13058 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T118 13076-13077 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T119 13127-13132 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T120 13151-13152 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T121 13153-13158 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T122 13346-13350 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T123 13346-13350 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T124 13423-13427 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T125 13423-13427 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T126 13448-13453 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T127 13588-13593 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T128 13594-13598 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T129 13594-13598 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T130 13608-13610 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T131 13620-13625 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T132 13655-13664 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T133 13718-13722 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T134 13718-13722 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T135 13767-13768 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T136 13801-13802 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T137 13893-13902 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T138 14027-14032 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T139 14054-14058 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T140 14054-14058 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T141 14270-14271 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T142 14302-14307 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T143 14334-14339 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T144 14398-14402 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T145 14398-14402 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T146 14444-14453 http://purl.obolibrary.org/obo/SO_0000418 denotes signaling
T147 14624-14628 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T148 14624-14628 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T149 14825-14838 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T150 14891-14896 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T151 15096-15099 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T152 15183-15186 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T153 15239-15244 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T154 15256-15284 http://purl.obolibrary.org/obo/CL_0000784 denotes plasmacytoid dendritic cells
T155 15288-15289 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T156 15290-15295 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T157 15364-15374 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T158 15428-15431 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T159 15526-15531 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T160 15626-15627 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T161 15688-15693 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T162 15801-15802 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T163 15809-15811 http://purl.obolibrary.org/obo/CLO_0052676 denotes Fc
T164 15827-15830 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T165 15937-15940 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T166 15946-15952 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T167 15974-15979 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T168 16116-16117 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T169 16552-16555 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T170 17137-17140 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T171 17150-17151 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T172 17795-17796 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T173 17980-17988 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T174 17993-17994 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T175 18045-18046 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T176 18804-18812 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T177 18889-18892 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T178 19047-19048 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T179 19751-19754 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T180 20115-20116 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T181 20511-20512 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T182 20656-20660 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T183 20656-20660 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T184 20840-20844 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T185 20840-20844 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T186 21158-21159 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T187 21381-21384 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T188 21402-21403 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T189 21608-21609 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T190 21932-21933 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 233-237 Chemical denotes beta http://purl.obolibrary.org/obo/CHEBI_10545
T2 744-759 Chemical denotes antiviral drugs http://purl.obolibrary.org/obo/CHEBI_36044
T3 744-753 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T4 754-759 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T5 934-954 Chemical denotes anti-rheumatic drugs http://purl.obolibrary.org/obo/CHEBI_35842
T6 949-954 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T7 993-1003 Chemical denotes antivirals http://purl.obolibrary.org/obo/CHEBI_22587
T8 1052-1057 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T9 1232-1234 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T11 1246-1248 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T13 1316-1327 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T14 1392-1401 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T15 1448-1458 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T16 1487-1490 Chemical denotes PD1 http://purl.obolibrary.org/obo/CHEBI_138655
T17 1591-1596 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T18 1989-1994 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T19 2001-2003 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T21 2015-2017 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T23 2475-2479 Chemical denotes beta http://purl.obolibrary.org/obo/CHEBI_10545
T24 3566-3571 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T25 3591-3601 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T26 3606-3617 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T27 4226-4236 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T28 4299-4307 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T29 6298-6303 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T30 6389-6398 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T31 6399-6408 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T32 6534-6539 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T33 6563-6576 Chemical denotes antimalarials http://purl.obolibrary.org/obo/CHEBI_38068
T34 6618-6623 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T35 7040-7052 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T36 7146-7157 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T37 7375-7382 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T38 7404-7411 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T39 7530-7541 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T40 7546-7558 Chemical denotes antimalarial http://purl.obolibrary.org/obo/CHEBI_38068
T41 7559-7563 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T42 7777-7795 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T43 7842-7853 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T44 7993-8004 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T45 8187-8198 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T46 8228-8232 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T47 8412-8423 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T48 8427-8445 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T49 8701-8713 Chemical denotes antimalarial http://purl.obolibrary.org/obo/CHEBI_38068
T50 8714-8719 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T51 8764-8773 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T52 8904-8924 Chemical denotes anti-rheumatic drugs http://purl.obolibrary.org/obo/CHEBI_35842
T53 8919-8924 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T54 8973-8980 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T55 9834-9843 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T56 10025-10027 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T58 10032-10034 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T60 10287-10289 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T62 10444-10446 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T64 10732-10739 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T65 10871-10882 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T66 11156-11158 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T68 11403-11405 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T70 11568-11570 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T72 11697-11701 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T73 11881-11883 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T74 11987-11994 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T75 12216-12223 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T76 13829-13839 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T77 13906-13911 Chemical denotes alpha http://purl.obolibrary.org/obo/CHEBI_30216
T78 13916-13920 Chemical denotes beta http://purl.obolibrary.org/obo/CHEBI_10545
T79 14795-14805 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T80 14981-14991 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T81 15554-15564 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T82 15819-15826 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T83 16074-16084 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T84 16148-16157 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T85 16164-16167 Chemical denotes PD1 http://purl.obolibrary.org/obo/CHEBI_138655
T86 17600-17615 Chemical denotes glucocorticoids http://purl.obolibrary.org/obo/CHEBI_24261
T87 18391-18402 Chemical denotes Chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T88 18407-18425 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T89 18535-18540 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T90 18599-18610 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T91 19138-19152 Chemical denotes glucocorticoid http://purl.obolibrary.org/obo/CHEBI_24261
T92 19912-19923 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T93 20355-20373 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T94 20572-20574 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T96 20605-20615 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 883-895 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T2 1022-1037 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T3 3584-3601 http://purl.obolibrary.org/obo/GO_0033673 denotes kinase inhibitors
T4 6691-6706 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T5 6842-6854 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T6 9118-9139 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T7 9382-9391 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T8 9618-9633 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T9 9642-9658 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T10 9821-9830 http://purl.obolibrary.org/obo/GO_0009058 denotes synthesis
T11 11390-11399 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T12 11844-11853 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T13 11888-11897 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T14 12086-12115 http://purl.obolibrary.org/obo/GO_0006898 denotes receptor-mediated endocytosis
T15 12104-12115 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis
T16 12134-12177 http://purl.obolibrary.org/obo/GO_0048259 denotes regulators of receptor mediated endocytosis
T17 12148-12177 http://purl.obolibrary.org/obo/GO_0006898 denotes receptor mediated endocytosis
T18 12166-12177 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis
T19 12324-12361 http://purl.obolibrary.org/obo/GO_0048261 denotes inhibit receptor mediated endocytosis
T20 12332-12361 http://purl.obolibrary.org/obo/GO_0006898 denotes receptor mediated endocytosis
T21 12350-12361 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis
T22 12680-12692 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T23 13088-13110 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immune response
T24 13095-13110 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T25 13263-13278 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T26 13655-13664 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T27 13893-13902 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T28 14286-14307 http://purl.obolibrary.org/obo/GO_0009615 denotes response to the virus
T29 14444-14461 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathway
T30 14444-14453 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T31 14522-14537 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T32 14549-14566 http://purl.obolibrary.org/obo/GO_0019079 denotes viral replication
T33 14549-14566 http://purl.obolibrary.org/obo/GO_0019058 denotes viral replication
T34 14589-14604 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T35 15046-15086 http://purl.obolibrary.org/obo/GO_0050777 denotes negatively regulates the immune response
T36 15071-15086 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T37 15124-15145 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T38 15353-15374 http://purl.obolibrary.org/obo/GO_0042116 denotes macrophage activation
T39 15496-15510 http://purl.obolibrary.org/obo/GO_0072647 denotes IFN production
T40 16881-16890 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T41 20870-20885 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 529-549 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T2 562-576 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T3 1274-1288 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T4 1942-1962 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T5 2062-2076 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T6 2335-2355 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T7 2745-2764 Phenotype denotes respiratory illness http://purl.obolibrary.org/obo/HP_0002086
T8 3744-3769 Phenotype denotes Cytokine Release Syndrome http://purl.obolibrary.org/obo/HP_0033041
T9 3798-3812 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T10 5675-5680 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T11 5682-5687 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T12 5689-5696 Phenotype denotes myalgia http://purl.obolibrary.org/obo/HP_0003326
T13 5701-5708 Phenotype denotes fatigue http://purl.obolibrary.org/obo/HP_0012378
T14 5738-5747 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T15 5952-5971 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T16 5981-6001 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T17 9145-9168 Phenotype denotes diffuse alveolar damage http://purl.obolibrary.org/obo/HP_0033006
T18 9226-9231 Phenotype denotes edema http://purl.obolibrary.org/obo/HP_0000969
T19 9329-9352 Phenotype denotes diffuse alveolar damage http://purl.obolibrary.org/obo/HP_0033006
T20 10398-10412 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T21 10506-10526 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T22 10537-10556 Phenotype denotes autoimmune diseases http://purl.obolibrary.org/obo/HP_0002960
T23 10822-10847 Phenotype denotes cytokine release syndrome http://purl.obolibrary.org/obo/HP_0033041
T24 11209-11229 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T25 11716-11736 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T26 13346-13358 Phenotype denotes lung disease http://purl.obolibrary.org/obo/HP_0002088
T27 13594-13606 Phenotype denotes lung disease http://purl.obolibrary.org/obo/HP_0002088
T28 14054-14066 Phenotype denotes lung disease http://purl.obolibrary.org/obo/HP_0002088
T29 14398-14410 Phenotype denotes lung disease http://purl.obolibrary.org/obo/HP_0002088
T30 14884-14890 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T31 15980-15986 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T32 17932-17952 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T33 18743-18752 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T34 19986-19995 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T35 20656-20668 Phenotype denotes lung disease http://purl.obolibrary.org/obo/HP_0002088

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-93 Sentence denotes Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
T2 95-103 Sentence denotes Abstract
T3 104-267 Sentence denotes The Coronavirus-associated disease, that was first identified in 2019 in China (CoViD-19), is a pandemic caused by a bat-derived beta-coronavirus, named SARS-CoV2.
T4 268-370 Sentence denotes It shares homology with SARS and MERS-CoV, responsible for past outbreaks in China and in Middle East.
T5 371-559 Sentence denotes SARS-CoV2 spread from China where the first infections were described in December 2019 and is responsible for the respiratory symptoms that can lead to acute respiratory distress syndrome.
T6 560-680 Sentence denotes A cytokine storm has been shown in patients who develop fatal complications, as observed in past coronavirus infections.
T7 681-842 Sentence denotes The management includes ventilatory support and broad-spectrum antiviral drugs, empirically utilized, as a targeted therapy and vaccines have not been developed.
T8 843-1038 Sentence denotes Based upon our limited knowledge on the pathogenesis of CoViD-19, a potential role of some anti-rheumatic drugs may be hypothesized, acting as direct antivirals or targeting host immune response.
T9 1039-1226 Sentence denotes Antimalarial drugs, commonly used in rheumatology, may alter the lysosomal proteases that mediates the viral entry into the cell and have demonstrated efficacy in improving the infection.
T10 1227-1370 Sentence denotes Anti-IL-1 and anti-IL-6 may interfere with the cytokine storm in severe cases and use of tocilizumab has shown good outcomes in a small cohort.
T11 1371-1435 Sentence denotes Baricitinib has both antiviral and anti-inflammatory properties.
T12 1436-1538 Sentence denotes Checkpoints inhibitors such as anti-CD200 and anti-PD1 could have a role in the treatment of CoViD-19.
T13 1539-1750 Sentence denotes Rheumatic disease patients taking immunosuppressive drugs should be recommended to maintain the chronic therapy, prevent infection by avoiding social contacts and pausing immunosuppressants in case of infection.
T14 1751-1859 Sentence denotes National and international registries are being created to collect data on rheumatic patients with CoViD-19.
T15 1861-1871 Sentence denotes Highlights
T16 1872-1972 Sentence denotes • CoViD-19 is a pandemic caused by SARS-CoV2, that can lead to acute respiratory distress syndrome.
T17 1973-2097 Sentence denotes • Antimalarial drugs, anti-IL-1 and anti-IL-6 may be used in severe cases targeting the cytokine storm induced by CoViD-19.
T18 2098-2212 Sentence denotes • Recommendations for rheumatic disease patients include the prevention of infection by avoiding social contacts.
T19 2213-2306 Sentence denotes • Patients should also continue their ongoing therapy except in the case of overt infection.
T20 2308-2364 Sentence denotes 1 SARS-CoV2 and the acute respiratory distress syndrome
T21 2365-2545 Sentence denotes Coronavirus Disease-2019 (CoViD-19) has emerged over the past months as a clinical syndrome caused by a novel beta-Coronavirus, named Severe Acute Respiratory Syndrome (SARS)-CoV2.
T22 2546-2787 Sentence denotes It was first reported in late December 2019 in Wuhan, China and the disease was officially named CoViD-19 by the World Health Organization (WHO) on February 11th, 2020 following an outbreak of acute respiratory illness in the Hubei province.
T23 2788-3013 Sentence denotes Since these earliest reports, this infection has spread in many countries worldwide with a significant rate of infection in Italy that currently accounts for more than 110,000 infected cases associated with 13,155 fatalities.
T24 3014-3065 Sentence denotes The WHO declared CoViD-19 a pandemic on March 11th.
T25 3066-3224 Sentence denotes The CoViD-19 pandemic has important implications for patients with rheumatic diseases, particularly those undergoing a variety of immunosuppressive therapies.
T26 3225-3490 Sentence denotes As it seems obvious that immunosuppressive therapy increases their risk of severe disease if infected with CoViD-19, many patients have the tendency to stop their immunosuppressive treatments, especially in highly impacted areas such as the Italian Lombardy region.
T27 3491-3844 Sentence denotes However, it is important to note that many commonly used immunosuppressive drugs such as JAK kinase inhibitors and tocilizumab have been proposed and/or used for the treatment of select patients who develop a frequently fatal clinical sequalae known as Cytokine Release Syndrome (CRS) (also referred to as “cytokine storm”) following CoViD-19 infection.
T28 3845-4180 Sentence denotes While data are changing rapidly and the disease trajectories can only be hypothesized, the issue whether to continue treating rheumatic disease patients needs to be addressed by the field of Rheumatology and other medical subspecialties, since some of these agents may be beneficial for specific phases or complications of the disease.
T29 4181-4348 Sentence denotes SARS-CoV2 is a positive single strand 30,000 nucleotide RNA virus that includes 14 open reading frames that encode 27 proteins and belongs to the Coronaviridae family.
T30 4349-4475 Sentence denotes Its phylogenetic data are consistent with the presence of a bat reservoir and subsequent spill over into the human population.
T31 4476-4700 Sentence denotes Sequencing data shows that SARS-CoV2 shares a high degree of sequence homology with a betacoronavirus isolated from bats termed Bat-CoV-RaTG13, suggesting that the Chinese chrysanthemum bat is the likely origin of SARS-CoV2.
T32 4701-4930 Sentence denotes Nonetheless, an unknown animal sold at the seafood market in Wuhan has been hypothesized to act as the intermediate host, as the first cases had common contacts in a market where no bats were present (bats hibernate in December).
T33 4931-5193 Sentence denotes In addition, SARS-CoV2 shares 79% and 50% gene homologies with the SARS Coronavirus (SARS-CoV) that was responsible for an outbreak in 2002 and with the Middle East Respiratory Syndrome (MERS)-CoV responsible for infections in Saudi Arabia in 2012, respectively.
T34 5194-5329 Sentence denotes Both these viruses had intermediate hosts that included the civet and camel, respectively, with humans serving as terminal hosts [1].""
T35 5330-5465 Sentence denotes Person-to-person transmission has already been established for SARS-CoV2 infection and reasoned to be mediated by respiratory droplets.
T36 5466-5616 Sentence denotes The current data also suggests that the elderly and patients with a compromised immune system are at a significantly higher risk and higher mortality.
T37 5617-5911 Sentence denotes The CoViD-19 infection is suspected when patients develop fever, cough, myalgia and fatigue, with bilateral interstitial pneumonia diagnosed in most patients (up to 76% in the earliest series) by ground glass opacity and patchy infiltrates in the chest as visualized by computerized tomography.
T38 5912-6265 Sentence denotes Around 20% of cases rapidly worsen into respiratory failure or acute respiratory distress syndrome (ARDS), requiring admission to the intensive care unit (ICU) with a mortality rate of approximately 2–3%, being highest in older age patients particularly those with chronic diseases and who are currently hospitalized in ICUs (up to 38%) [[2], [3], [4]].
T39 6266-6409 Sentence denotes Currently there are no specific drugs and/or vaccines for SARS-CoV2 infection, prompting the use of several broad-spectrum antiviral molecules.
T40 6410-6514 Sentence denotes In addition, an animal model to study the disease and test potential vaccines is at present missing [5].
T41 6516-6612 Sentence denotes 2 Anti-rheumatic drugs as possible therapies: antimalarials, anti-IL6, anti-IL1 and baricitinib
T42 6613-6837 Sentence denotes Some drugs usually used in rheumatologic field and targeting the host and its immune response seem to have the potential to interfere with CoViD-19 infection and their potential benefit is being studied in patients (Fig. 1).
T43 6838-7003 Sentence denotes The pathogenesis of CoViD-19 remains unclear, but modelling assays revealed a high degree of homology in the receptor binding domains between SARS-CoV2 and SARS-CoV.
T44 7004-7313 Sentence denotes All coronaviruses express a surface glycoprotein termed a “spike” which bind to the host receptor for viral entry that has been identified as angiotensin-converting enzyme 2 receptors (ACE2r) [1], expressed by mature lung epithelial cells, enterocytes, kidney proximal tubular cells and endothelial cells [6].
T45 7314-7459 Sentence denotes After receptor binding, lysosomal proteases cleave the spike protein releasing the signal peptide that facilitates viral entry into the cell [7].
T46 7460-7756 Sentence denotes These mechanisms may be targeted and interrupted by therapies such as chloroquine, an antimalarial drug, and preliminary data demonstrate that it may have clinical benefit in the management of CoViD-19 infected patients as determined by improved imaging and shortening of the diseases course [8].
T47 7757-8014 Sentence denotes We should note that hydroxychloroquine, which shares the same mechanism of action as chloroquine but has a better safety profile and is frequently used particularly in connective tissue disease, has a more potent anti-viral effect than chloroquine in vitro.
T48 8015-8318 Sentence denotes From the results of physiologically-based pharmacokinetic models, a loading dose of 800 mg orally followed by 400 mg daily for four days reaches three times the potency of chloroquine and is therefore a promising drug for both the prevention and the treatment of CoViD-19, with low risk of toxicity [9].
T49 8319-8467 Sentence denotes These findings have led to several clinical trials that are ongoing to study the efficacy of chloroquine or hydroxychloroquine in CoViD-19 patients.
T50 8468-8615 Sentence denotes Hydroxychloroquine is thus being used in Italy for the treatment of CoViD-19 patients despite the absence of efficacy data in the clinical setting.
T51 8616-8845 Sentence denotes In light of these data, the recommendation for rheumatic patients chronically taking antimalarial drugs is to not discontinue them, considering the antiviral efficacy and the immunomodulatory rather than immunosuppressive effect.
T52 8846-8950 Sentence denotes Fig. 1 Representation of possible mechanisms of action of anti-rheumatic drugs in coronavirus infection.
T53 8951-9032 Sentence denotes AAK1 = AP2-associated protein kinase 1; SARS = severe acute respiratory syndrome.
T54 9033-9169 Sentence denotes The pulmonary complications in human CoViD-19 patients are due to an exuberant local inflammatory response with diffuse alveolar damage.
T55 9170-9280 Sentence denotes Patients dying because of SARS have lung consolidation, edema and mucopurulent material in the bronchial tree.
T56 9281-9479 Sentence denotes At microscopic examination, alterations such as diffuse alveolar damage, hyaline membrane and fibrin formation, neutrophils and macrophages infiltrates were detected in the interstitium and alveoli.
T57 9480-9569 Sentence denotes Similar features were noted in the only human autopsy report available of MERS infection.
T58 9570-9756 Sentence denotes Cytokines and chemokines play a key role in the immune response against viral infections, and their altered production has been demonstrated in both SARS and MERS coronavirus infections.
T59 9757-9999 Sentence denotes Such altered levels have been shown to be likely due to the low synthesis of antiviral cytokines such as interferons (IFN)α or β and in concert increased levels of other pro-inflammatory cytokines/chemokines that have pathogenic consequences.
T60 10000-10200 Sentence denotes Among them, interleukin (IL)-1, IL-6 and other pro-inflammatory cytokines were shown to be significantly more elevated in patients with severe compared to uncomplicated SARS or MERS infection [10,11].
T61 10201-10422 Sentence denotes Recent preliminary data from China reported high plasma levels of cytokines including IL-6, related to the severity and the prognosis of the disease with a clear implication for the occurrence of “cytokine storm” and CRS.
T62 10423-10652 Sentence denotes Tocilizumab, an anti-IL-6 receptor antibody that has been used clinically to treat rheumatoid arthritis and other autoimmune diseases, has been used and approved for treatment of a variety of clinical conditions that include CRS.
T63 10653-10853 Sentence denotes These have included clinical conditions such as those associated with chimeric antigen receptor T-cell (CAR-T) therapy that appears to induce severe or life-threatening cytokine release syndrome [12].
T64 10854-11056 Sentence denotes A single dose of tocilizumab was used in 21 patients in China suffering from severe respiratory syndrome during CoViD-19 infection, at the dosage of 400 mg intravenously, in addition to routine therapy.
T65 11057-11251 Sentence denotes In a few days, 90% of patients recovered and lung opacities disappeared [13], suggesting that anti-IL-6 might be a powerful potential rescue therapy in respiratory distress syndrome of CoViD-19.
T66 11252-11409 Sentence denotes A potential role for anti-IL1 biologics could be hypothesized from data showing an activation of the NLRP3 inflammasome by SARS-CoV, with secretion of IL-1β.
T67 11410-11579 Sentence denotes Studies have demonstrated that inflammasome activation also occurs in SARS-CoV2 infection, especially within lymphoid cells and patients have increased serum IL-1β [14].
T68 11580-11898 Sentence denotes Another potential treatment under evaluation for SARS-CoV2 related acute respiratory disease is baricitinib, an oral drug used to treat rheumatoid arthritis patients that functions as a blocker of Janus Kinases (JAK) 1 and 2, enzymes associated with intracellular signaling, including Type I and type II IFN signaling.
T69 11899-12116 Sentence denotes One rationale for its use is based on the fact that viruses such as SARS-CoV2 utilize a protein expressed on its spike to bind to the ACE2 receptor and enter cells through a mechanism of receptor-mediated endocytosis.
T70 12117-12240 Sentence denotes One of the known regulators of receptor mediated endocytosis is a kinase termed the AP2-associated protein kinase 1 (AAK1).
T71 12241-12280 Sentence denotes Baricitinib has high affinity for AAK1.
T72 12281-12485 Sentence denotes Inhibition of AAK1 is reasoned to not only inhibit receptor mediated endocytosis (blocking intracellular entry of the virus) but it may also function in the intracellular assembly of virus particles [15].
T73 12486-12729 Sentence denotes The plasma concentration of baricitinib at its current therapeutic dosage (2 or 4 mg orally once daily) is sufficient to inhibit AAK1, thus it may be able to reduce both the viral entry and the inflammation characteristic of CoViD-19 patients.
T74 12730-12932 Sentence denotes Another important aspect in CoViD-19 is that patients are not able to initiate a valid and rapid type I IFN response [10], but the mechanisms underlying this defective response are not completely clear.
T75 12933-13147 Sentence denotes In SARS, macrophages and dendritic cells are only abortively infected and natural killer cells are not activated by the virus, thus suggesting a defective innate immune response with an altered virus clearance [6].
T76 13148-13436 Sentence denotes In a mouse model using the related coronavirus, delayed type-I IFN responses (with IFN levels peaking later in the immune response and remaining elevated) were associated with mortality from severe lung disease, due to recruitment of highly inflammatory macrophages into the lung [16,17].
T77 13437-13612 Sentence denotes Studies of human SARS-CoV infections also strongly suggest that dysregulated and persistently elevated type-I IFN responses are associated with severe human lung disease [18].
T78 13613-13742 Sentence denotes In the mouse model, absence of Type-I IFN signaling (achieved by knockout of the IFN-receptor) abolished lung mediated lethality.
T79 13743-13935 Sentence denotes These data also suggest a second possible explanation for a therapeutic effect of JAK inhibitors such as baricitinib, since they block the downstream signaling of alpha and beta IFN receptors.
T80 13936-14194 Sentence denotes The situation is complicated by the finding that very early administration of IFN-β in the mouse model also decreased lung disease, suggesting that timing and duration of type-I IFN responses is critical to whether the outcome is helpful or deleterious [16].
T81 14195-14255 Sentence denotes What does this imply for patients on JAK inhibition therapy?
T82 14256-14462 Sentence denotes They may have a decreased IFN response to the virus, which would cause excess virus replication, but they also might have less risk of severe lung disease due to downregulation of the IFN signaling pathway.
T83 14463-14644 Sentence denotes This illustrates the difficult balance between an adequate immune response to prevent viral replication and an over-exuberant immune response that causes severe lung pathology [17].
T84 14645-14762 Sentence denotes The role of type I IFN in SARS-CoV2 and the role of blocking IFN-I pathways therefore requires more detailed studies.
T85 14764-14805 Sentence denotes 3 The role of the checkpoints inhibitors
T86 14806-14941 Sentence denotes The evasion of the immune system checkpoints are often used by both malignant cancer cells and pathogens to escape immune surveillance.
T87 14942-15029 Sentence denotes One of the most interesting checkpoint inhibitors is the CD200-CD200R1 system (Fig. 1).
T88 15030-15173 Sentence denotes This checkpoint negatively regulates the immune response with the aim to prevent an excessive inflammatory response to different triggers [19].
T89 15174-15380 Sentence denotes Thus, it has been shown to down-modulate TLR7 (single strand RNA virus sensor) in plasmacytoid dendritic cells of a mouse model of coronavirus infection [20] and to down-modulate macrophage activation [21].
T90 15381-15542 Sentence denotes Interestingly, the inhibition of CD200-CD200R1 has positive effects on coronavirus infection [19,20,22], restoring IFN production and increasing virus clearance.
T91 15543-15800 Sentence denotes Checkpoint inhibitors are currently and effectively used as therapeutic agents for a variety of cancers, but have only minimally been studied in human infectious diseases, although their function was clearly defined using the murine model of LCMV infection.
T92 15801-16115 Sentence denotes A CD200-Fc fusion protein has been successfully used in experimental settings [21] and trials on inhibitory antibody targeting of CD200 has been tested for the treatment of human cancer [19], thus suggesting the intriguing possibility to use currently available checkpoint inhibitors for the treatment of CoViD-19.
T93 16116-16206 Sentence denotes A trial with another checkpoint inhibitor, anti-PD1, is also ongoing in CoViD-19 patients.
T94 16208-16272 Sentence denotes 4 Management of rheumatic patients during the CoViD-19 pandemic
T95 16273-16460 Sentence denotes The scientific research on SARS-CoV2 and its possible therapies are based on the knowledge of previous coronaviruses and on data recently made available by the Chinese scientific society.
T96 16461-16636 Sentence denotes Likewise, social and health policy, information and containment measures are based on what has been learned from previous epidemics, in order to optimize the current measures.
T97 16637-17063 Sentence denotes From the epidemiology of SARS-CoV and SARS-CoV2 in China we have learned how fundamental are measures such as early recognition of the problem, strict infection control and identification of infected patients, isolation measures, inclusion and formation of new medical and sanitary staff in the health system, designation of new hospital wards with appropriate equipment and information through the mass and social media [14].
T98 17064-17370 Sentence denotes As part of these measures, recently, the Italian Society of Rheumatology has proposed a set of practical recommendations to improve the management of CoViD-19 patients and to decrease the risk of acquiring this infection in particular in rheumatic patients undergoing immunosuppressive therapies (Table 1).
T99 17371-17685 Sentence denotes In general, the interruption of therapies used in rheumatic patients is not advised, as it may be responsible for the onset of clinical flares of the rheumatic disease with subsequent use of other immunosuppressants such as oral glucocorticoids that may be equally unsafe for patients in case of acquired CoViD-19.
T100 17686-17873 Sentence denotes Although the data are at present unavailable, it appears important to maintain chronic therapies and to have a strict control of each patient in order to evaluate specific clinical needs.
T101 17874-18077 Sentence denotes In fact, the infection risk in rheumatic diseases such as rheumatoid arthritis is also related to disease activity and a flare due to therapy discontinuation would confer a higher risk of infection [23].
T102 18078-18159 Sentence denotes Table 1 Recommendations proposed for rheumatic diseases during CoViD-19 pandemic.
T103 18160-18209 Sentence denotes 1- Do not discontinue immunosuppressive treatment
T104 18210-18358 Sentence denotes 2- Follow the recommendations for infection prevention suggested by the Italian Ministry of Health, in particular avoid contact with crowded places.
T105 18359-18387 Sentence denotes Smart working is encouraged.
T106 18388-18476 Sentence denotes 3- Chloroquine and hydroxychloroquine seem to have some efficacy on SARS-CoV2 infection.
T107 18477-18584 Sentence denotes 4- Chronic immunomodulatory therapies, including biologic drugs, must be guaranteed for rheumatic patients.
T108 18585-18759 Sentence denotes This includes tocilizumab and baricitinib availability for patients chronically taking these compounds, as they may start to be used to treat CoViD-19 severe pneumonia cases.
T109 18760-18967 Sentence denotes 5- Outpatients clinics, albeit with limited activity, should be guaranteed for biologic therapies, as the National Health System has authorized people to move for very specific reasons such as health issues.
T110 18968-19079 Sentence denotes For all patients, consulting should be made available using media that exclude a person-to-person relationship.
T111 19080-19307 Sentence denotes For the same reason, rheumatic patients on long term oral glucocorticoid treatment should not only never stop these abruptly but in addition it should be kept in mind that ending of such therapy may also lead to adrenal crisis.
T112 19308-19476 Sentence denotes Prevention measures suggested by the Italian Ministry of Health must be applied to everyone, in particular by rheumatic patients undergoing immunosuppressive therapies.
T113 19477-19567 Sentence denotes Patients are therefore strongly encouraged to avoid social contact and maintain isolation.
T114 19568-19908 Sentence denotes Chronic therapies will be guaranteed for rheumatic patients also in these weeks of CoViD-19 outbreak in which the routine outpatient clinics are closed, as the National Health System has authorized people to move for very specific reasons such as health issues and the need for biologic therapies which are available only in some hospitals.
T115 19909-20111 Sentence denotes As tocilizumab and baricitinib may start to be used to treat CoViD-19 severe pneumonia cases, their availability must be guaranteed for the treatment of rheumatic patients who are using these compounds.
T116 20112-20333 Sentence denotes If a rheumatic patient develops symptoms of any infection, it is important to follow the guidelines suggested by the rheumatology community and immunosuppressive therapy should be paused for the duration of the infection.
T117 20334-20531 Sentence denotes The one exception is hydroxychloroquine, which may have therapeutic potential for CoViD-19 infection and should therefore not be stopped in patients who have been taking it for a rheumatic disease.
T118 20532-20787 Sentence denotes As mentioned above, it is possible that IL-6 blockade and the use of JAK inhibitors could have beneficial effects on severe lung disease, but we don't yet know enough to recommend continuing these agents, since they could adversely affect viral clearance.
T119 20788-20983 Sentence denotes Much more study of the kinetics of SARS-CoV2 in the lung, and the relation of the immune response to the onset of CRS, is therefore needed to clarify recommendations for patients on these agents.
T120 20984-21146 Sentence denotes The epidemiological scenario is rapidly changing daily and we still have no knowledge about the infection rate and course of CoViD-19 in rheumatologic conditions.
T121 21147-21344 Sentence denotes Therefore, a national or international registry is strongly encouraged to understand the impact of the infection on specific rheumatic diseases or treatments and the risk factors for poor outcomes.
T122 21345-21456 Sentence denotes The Italian Society of Rheumatology has established such a registry in March 2020 and data are being collected.
T123 21457-21629 Sentence denotes Although our observations have no epidemiological grounds, we are quite surprised by the limited number of rheumatic patients contacting us because of a CoViD-19 infection.
T124 21630-21812 Sentence denotes Furthermore, an international registry supported by America College of Rheumatology, European League Against Rheumatism and other rheumatologic societies worldwide is being launched.
T125 21813-21998 Sentence denotes In the meantime, it is important that patients are reassured and consultations made available using media that exclude a person-to-person relationship to minimize the risk of infection.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1 20-31 NCBITaxon:11118 denotes coronavirus
T2 108-119 NCBITaxon:11118 denotes Coronavirus
T3 184-192 SP_7 denotes CoViD-19
T4 221-224 SP_2 denotes bat
T5 238-249 NCBITaxon:11118 denotes coronavirus
T6 257-266 SP_7 denotes SARS-CoV2
T7 278-286 SO:0000853 denotes homology
T8 292-296 SP_10 denotes SARS
T9 301-309 SP_9 denotes MERS-CoV
T10 371-380 SP_7 denotes SARS-CoV2
T11 485-496 UBERON:0001004 denotes respiratory
T12 529-540 UBERON:0001004 denotes respiratory
T13 657-668 NCBITaxon:11118 denotes coronavirus
T14 754-759 CHEBI:36044;CHEBI:36044 denotes drugs
T15 899-907 SP_7 denotes CoViD-19
T16 934-939 CHEBI:67079;CHEBI:67079 denotes anti-
T17 949-954 CHEBI:23888;CHEBI:23888 denotes drugs
T18 1017-1021 GO:0006955 denotes host
T19 1022-1028 UBERON:0002405;GO:0006955 denotes immune
T20 1029-1037 GO:0006955 denotes response
T21 1039-1051 CHEBI:38068;CHEBI:38068 denotes Antimalarial
T22 1052-1057 CHEBI:23888;CHEBI:23888 denotes drugs
T23 1104-1113 GO:0005764 denotes lysosomal
T24 1142-1147 NCBITaxon:10239;GO:0035376 denotes viral
T25 1148-1158 GO:0035376 denotes entry into
T26 1246-1250 PR:000001393 denotes IL-6
T27 1316-1327 DG_35 denotes tocilizumab
T28 1371-1382 CHEBI:3213;DG_41;CHEBI:3213 denotes Baricitinib
T29 1436-1447 GO:0000075 denotes Checkpoints
T30 1448-1458 CHEBI:35222;CHEBI:35222 denotes inhibitors
T31 1472-1477 PR:000001829 denotes CD200
T32 1487-1490 PR:000001919 denotes PD1
T33 1529-1537 SP_7 denotes CoViD-19
T34 1573-1590 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T35 1591-1596 CHEBI:23888;CHEBI:23888 denotes drugs
T36 1710-1728 CHEBI:35705;CHEBI:35705 denotes immunosuppressants
T37 1850-1858 SP_7 denotes CoViD-19
T38 1875-1883 SP_7 denotes CoViD-19
T39 1908-1917 SP_7 denotes SARS-CoV2
T40 1942-1953 UBERON:0001004 denotes respiratory
T41 1976-1988 CHEBI:38068;CHEBI:38068 denotes Antimalarial
T42 1989-1994 CHEBI:23888;CHEBI:23888 denotes drugs
T43 2015-2019 PR:000001393 denotes IL-6
T44 2088-2096 SP_7 denotes CoViD-19
T52 2311-2320 SP_7 denotes SARS-CoV2
T53 2335-2346 UBERON:0001004 denotes respiratory
T54 2365-2376 NCBITaxon:11118 denotes Coronavirus
T55 2391-2399 SP_7 denotes CoViD-19
T56 2480-2491 NCBITaxon:11118 denotes Coronavirus
T57 2534-2538 SP_10 denotes SARS
T58 2643-2651 SP_7 denotes CoViD-19
T59 2745-2756 UBERON:0001004 denotes respiratory
T60 3031-3039 SP_7 denotes CoViD-19
T61 3070-3078 SP_7 denotes CoViD-19
T62 3196-3213 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T63 3250-3267 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T64 3332-3340 SP_7 denotes CoViD-19
T65 3388-3405 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T66 3548-3565 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T67 3566-3571 CHEBI:23888;CHEBI:23888 denotes drugs
T68 3591-3601 CHEBI:35222;CHEBI:35222 denotes inhibitors
T69 3606-3617 DG_35 denotes tocilizumab
T70 3825-3833 SP_7 denotes CoViD-19
T71 4181-4190 SP_7 denotes SARS-CoV2
T72 4237-4240 BV_22 denotes RNA
T73 4241-4246 BV_22;NCBITaxon:10239 denotes virus
T74 4264-4283 SO:0000236 denotes open reading frames
T75 4327-4340 NCBITaxon:11118 denotes Coronaviridae
T76 4409-4412 SP_2 denotes bat
T77 4458-4463 SP_6;NCBITaxon:9606 denotes human
T78 4503-4512 SP_7 denotes SARS-CoV2
T79 4546-4554 SO:0000853 denotes homology
T80 4562-4577 SP_8;NCBITaxon:694002 denotes betacoronavirus
T81 4592-4596 SP_2;NCBITaxon:6960 denotes bats
T82 4608-4611 NCBITaxon:11118 denotes CoV
T83 4662-4665 SP_2 denotes bat
T84 4690-4699 SP_7 denotes SARS-CoV2
T85 4725-4731 NCBITaxon:33208 denotes animal
T86 4883-4887 SP_2;NCBITaxon:9397 denotes bats
T87 4902-4906 SP_2;NCBITaxon:9397 denotes bats
T88 4944-4953 SP_7 denotes SARS-CoV2
T89 4973-4977 SO:0000704 denotes gene
T90 4978-4988 SO:0000853 denotes homologies
T91 4998-5002 SP_10 denotes SARS
T92 5003-5014 NCBITaxon:11118 denotes Coronavirus
T93 5016-5024 SP_10 denotes SARS-CoV
T94 5118-5122 SP_9 denotes MERS
T95 5205-5212 NCBITaxon:10239 denotes viruses
T96 5264-5269 SP_3 denotes camel
T97 5290-5296 NCBITaxon:9606 denotes humans
T98 5330-5336 NCBITaxon:9606 denotes Person
T99 5340-5346 NCBITaxon:9606 denotes person
T100 5393-5402 SP_7 denotes SARS-CoV2
T101 5444-5455 UBERON:0001004 denotes respiratory
T102 5546-5559 UBERON:0002405 denotes immune system
T103 5621-5629 SP_7 denotes CoViD-19
T104 5725-5737 UBERON:0005169 denotes interstitial
T105 5864-5869 UBERON:0001443 denotes chest
T106 5952-5963 UBERON:0001004 denotes respiratory
T107 5981-5992 UBERON:0001004 denotes respiratory
T108 6056-6060 UBERON:0007221 denotes care
T109 6298-6303 CHEBI:23888;CHEBI:23888 denotes drugs
T110 6324-6333 SP_7 denotes SARS-CoV2
T111 6399-6408 CHEBI:36357;CHEBI:36357 denotes molecules
T112 6426-6432 NCBITaxon:33208 denotes animal
T113 6519-6523 CHEBI:35472;CHEBI:35472 denotes Anti
T114 6523-6524 CHEBI:67079;CHEBI:67079 denotes -
T115 6534-6539 CHEBI:23888;CHEBI:23888 denotes drugs
T116 6583-6586 PR:000001393 denotes IL6
T117 6601-6612 DG_41 denotes baricitinib
T118 6618-6623 CHEBI:23888;CHEBI:23888 denotes drugs
T119 6691-6697 UBERON:0002405;GO:0006955 denotes immune
T120 6698-6706 GO:0006955 denotes response
T121 6752-6760 SP_7 denotes CoViD-19
T122 6858-6866 SP_7 denotes CoViD-19
T123 6931-6939 SO:0000853 denotes homology
T124 6964-6971 SO:0000417 denotes domains
T125 6980-6989 SP_7 denotes SARS-CoV2
T126 6994-7002 SP_10 denotes SARS-CoV
T127 7008-7021 NCBITaxon:11118 denotes coronaviruses
T128 7022-7029 GO:0010467 denotes express
T129 7032-7039 GO:0009986 denotes surface
T130 7040-7052 CHEBI:17089;BV_11;CHEBI:17089 denotes glycoprotein
T131 7106-7111 NCBITaxon:10239 denotes viral
T132 7146-7177 PG_10;PR:000003622 denotes angiotensin-converting enzyme 2
T133 7189-7194 G_3;PG_10;PR:000003622 denotes ACE2r
T134 7201-7210 GO:0010467 denotes expressed
T135 7221-7225 CL:0000082;UBERON:0002048 denotes lung
T136 7226-7236 UBERON:0000115;CL:0000066 denotes epithelial
T137 7237-7242 CL:0000066 denotes cells
T138 7244-7255 CL:0000584 denotes enterocytes
T139 7257-7263 UBERON:0002113 denotes kidney
T140 7291-7302 UBERON:0001986;CL:0000115 denotes endothelial
T141 7303-7308 CL:0000115 denotes cells
T142 7338-7347 GO:0005764 denotes lysosomal
T143 7358-7364 MOP:0000780 denotes cleave
T144 7429-7434 NCBITaxon:10239;GO:0035376 denotes viral
T145 7435-7445 GO:0035376 denotes entry into
T146 7530-7541 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T147 7546-7558 CHEBI:35718;CHEBI:35718 denotes antimalarial
T148 7559-7563 CHEBI:23888;CHEBI:23888 denotes drug
T149 7653-7661 SP_7 denotes CoViD-19
T150 7777-7795 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T151 7842-7853 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T152 7925-7942 UBERON:0002384 denotes connective tissue
T153 7975-7980 NCBITaxon:10239 denotes viral
T154 7993-8004 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T155 8057-8072 CHEBI:52217;CHEBI:52217 denotes pharmacokinetic
T156 8187-8198 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T157 8228-8232 CHEBI:23888;CHEBI:23888 denotes drug
T158 8278-8286 SP_7 denotes CoViD-19
T159 8412-8423 CHEBI:3638;DG_10;CHEBI:3638 denotes chloroquine
T160 8427-8445 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T161 8449-8457 SP_7 denotes CoViD-19
T162 8468-8486 CHEBI:5801;DG_20;CHEBI:5801 denotes Hydroxychloroquine
T163 8536-8544 SP_7 denotes CoViD-19
T164 8701-8713 CHEBI:38068;CHEBI:38068 denotes antimalarial
T165 8714-8719 CHEBI:23888;CHEBI:23888 denotes drugs
T166 8820-8837 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T167 8904-8918 CHEBI:35472;CHEBI:35472 denotes anti-rheumatic
T168 8919-8924 CHEBI:23888;CHEBI:23888 denotes drugs
T169 8928-8939 NCBITaxon:11118 denotes coronavirus
T170 8951-8955 PR:000003526 denotes AAK1
T171 8958-8989 PR:000003526 denotes AP2-associated protein kinase 1
T172 8991-8995 SP_10 denotes SARS
T173 9011-9022 UBERON:0001004 denotes respiratory
T181 9037-9046 UBERON:0002048 denotes pulmonary
T182 9064-9069 SP_6;NCBITaxon:9606 denotes human
T183 9070-9078 SP_7 denotes CoViD-19
T184 9153-9161 UBERON:0003215 denotes alveolar
T185 9179-9184 GO:0016265 denotes dying
T186 9196-9200 SP_10 denotes SARS
T187 9206-9210 UBERON:0002048 denotes lung
T188 9265-9279 UBERON:0007196 denotes bronchial tree
T189 9337-9345 UBERON:0003215 denotes alveolar
T190 9375-9381 CHEBI:5054;CHEBI:5054 denotes fibrin
T191 9393-9404 CL:0000775 denotes neutrophils
T192 9409-9420 CL:0000235 denotes macrophages
T193 9454-9466 UBERON:0005169 denotes interstitium
T194 9471-9478 UBERON:0003215 denotes alveoli
T195 9520-9525 SP_6;NCBITaxon:9606 denotes human
T196 9554-9558 SP_9 denotes MERS
T197 9618-9624 UBERON:0002405;GO:0006955 denotes immune
T198 9625-9633 GO:0006955 denotes response
T199 9642-9647 NCBITaxon:10239 denotes viral
T200 9719-9723 SP_10 denotes SARS
T201 9728-9732 SP_9;NCBITaxon:8088 denotes MERS
T202 9733-9744 NCBITaxon:11118 denotes coronavirus
T203 10032-10036 PR:000001393 denotes IL-6
T204 10169-10173 SP_10 denotes SARS
T205 10177-10181 SP_9 denotes MERS
T206 10250-10256 UBERON:0001969 denotes plasma
T207 10287-10291 PR:000001393 denotes IL-6
T208 10423-10434 DG_35 denotes Tocilizumab
T209 10444-10448 PR:000001393 denotes IL-6
T210 10458-10466 GO:0042571 denotes antibody
T211 10537-10547 UBERON:0002405 denotes autoimmune
T212 10732-10739 CHEBI:59132;CHEBI:59132 denotes antigen
T213 10749-10755 CL:0000084 denotes T-cell
T214 10805-10809 UBERON:0000104 denotes life
T215 10871-10882 DG_35 denotes tocilizumab
T216 10938-10949 UBERON:0001004 denotes respiratory
T217 10966-10974 SP_7 denotes CoViD-19
T218 11102-11106 UBERON:0002048 denotes lung
T219 11156-11160 PR:000001393 denotes IL-6
T220 11209-11220 UBERON:0001004 denotes respiratory
T221 11242-11250 SP_7 denotes CoViD-19
T222 11353-11358 PR:000011271 denotes NLRP3
T223 11375-11383 SP_10 denotes SARS-CoV
T224 11441-11464 GO:0002437 denotes inflammasome activation
T225 11480-11489 SP_7 denotes SARS-CoV2
T226 11519-11533 CL:0000542 denotes lymphoid cells
T227 11562-11567 UBERON:0001977 denotes serum
T228 11568-11573 PR:000001136 denotes IL-1β
T229 11629-11638 SP_7 denotes SARS-CoV2
T230 11653-11664 UBERON:0001004 denotes respiratory
T231 11676-11687 DG_41 denotes baricitinib
T232 11692-11696 UBERON:0000165 denotes oral
T233 11697-11701 CHEBI:23888;CHEBI:23888 denotes drug
T234 11830-11843 GO:0005622;GO:0035556 denotes intracellular
T235 11844-11853 GO:0035556 denotes signaling
T236 11884-11887 GO:0035556 denotes IFN
T237 11888-11897 GO:0008543 denotes signaling
T238 11951-11958 NCBITaxon:10239 denotes viruses
T239 11967-11976 SP_7 denotes SARS-CoV2
T240 11995-12004 GO:0010467 denotes expressed
T241 12033-12037 G_3;PG_10;PR:000003622 denotes ACE2
T242 12051-12062 CL:0000584 denotes enter cells
T243 12104-12115 GO:0006898 denotes endocytosis
T244 12166-12177 GO:0048259 denotes endocytosis
T245 12201-12232 PR:000003526 denotes AP2-associated protein kinase 1
T246 12234-12238 PR:000003526 denotes AAK1
T247 12241-12252 CHEBI:3213;DG_41;CHEBI:3213 denotes Baricitinib
T248 12275-12279 PR:000003526 denotes AAK1
T249 12295-12299 PR:000003526 denotes AAK1
T250 12350-12361 GO:0006898 denotes endocytosis
T251 12372-12385 GO:0005622;GO:0035376 denotes intracellular
T252 12386-12391 GO:0035376 denotes entry
T253 12399-12404 NCBITaxon:10239 denotes virus
T254 12438-12451 GO:0005622;GO:0046907 denotes intracellular
T255 12452-12460 GO:0046907 denotes assembly
T256 12464-12469 NCBITaxon:10239 denotes virus
T257 12490-12496 UBERON:0001969 denotes plasma
T258 12514-12525 DG_41 denotes baricitinib
T259 12615-12619 PR:000003526 denotes AAK1
T260 12660-12665 NCBITaxon:10239;GO:0035376 denotes viral
T261 12666-12671 GO:0035376 denotes entry
T262 12711-12719 SP_7 denotes CoViD-19
T263 12758-12766 SP_7 denotes CoViD-19
T264 12936-12940 SP_10 denotes SARS
T265 12942-12953 CL:0000235 denotes macrophages
T266 12958-12967 GO:0030425;CL:0000451 denotes dendritic
T267 12968-12973 CL:0000451 denotes cells
T268 13007-13027 CL:0000623 denotes natural killer cells
T269 13053-13058 NCBITaxon:10239 denotes virus
T270 13088-13094 GO:0045087 denotes innate
T271 13095-13101 GO:0045087;UBERON:0002405 denotes immune
T272 13102-13110 GO:0045087 denotes response
T273 13127-13132 NCBITaxon:10239 denotes virus
T274 13153-13158 NCBITaxon:10088 denotes mouse
T275 13183-13194 NCBITaxon:11118 denotes coronavirus
T276 13263-13269 UBERON:0002405;GO:0006955 denotes immune
T277 13270-13278 GO:0006955 denotes response
T278 13346-13350 UBERON:0002048 denotes lung
T279 13389-13413 CL:0000863 denotes inflammatory macrophages
T280 13423-13427 UBERON:0002048 denotes lung
T281 13448-13453 SP_6;NCBITaxon:9606 denotes human
T282 13454-13462 SP_10 denotes SARS-CoV
T283 13501-13513 GO:0065007 denotes dysregulated
T284 13588-13593 SP_6;NCBITaxon:9606 denotes human
T285 13594-13598 UBERON:0002048 denotes lung
T286 13620-13625 NCBITaxon:10088 denotes mouse
T287 13651-13664 GO:0008543 denotes IFN signaling
T288 13718-13722 UBERON:0002048 denotes lung
T289 13829-13839 CHEBI:35222;CHEBI:35222 denotes inhibitors
T290 13848-13859 DG_41 denotes baricitinib
T291 14014-14019 PR:000008924 denotes IFN-β
T292 14027-14032 NCBITaxon:10088 denotes mouse
T293 14054-14058 UBERON:0002048 denotes lung
T294 14302-14307 NCBITaxon:10239 denotes virus
T295 14334-14339 NCBITaxon:10239;GO:0006260 denotes virus
T296 14340-14351 GO:0006260 denotes replication
T297 14398-14402 UBERON:0002048 denotes lung
T298 14440-14443 GO:0008543 denotes IFN
T299 14522-14528 UBERON:0002405;GO:0006955 denotes immune
T300 14529-14537 GO:0006955 denotes response
T301 14549-14554 NCBITaxon:10239;GO:0006260 denotes viral
T302 14555-14566 GO:0006260 denotes replication
T303 14589-14595 UBERON:0002405;GO:0006955 denotes immune
T304 14596-14604 GO:0006955 denotes response
T305 14624-14628 UBERON:0002048 denotes lung
T306 14671-14680 SP_7 denotes SARS-CoV2
T307 14783-14794 GO:0000075 denotes checkpoints
T308 14795-14805 CHEBI:35222;CHEBI:35222 denotes inhibitors
T309 14825-14838 UBERON:0002405 denotes immune system
T310 14839-14850 GO:0000075 denotes checkpoints
T311 14921-14927 UBERON:0002405 denotes immune
T312 14928-14940 GO:0065007 denotes surveillance
T313 14970-14980 GO:0000075 denotes checkpoint
T314 14981-14991 CHEBI:35222;CHEBI:35222 denotes inhibitors
T315 14999-15004 PR:000001829 denotes CD200
T316 15005-15012 PR:000005161 denotes CD200R1
T317 15035-15045 GO:0000075 denotes checkpoint
T318 15071-15077 UBERON:0002405;GO:0006955 denotes immune
T319 15078-15086 GO:0006955 denotes response
T320 15215-15219 PR:000001158 denotes TLR7
T321 15235-15238 BV_22 denotes RNA
T322 15239-15244 BV_22;NCBITaxon:10239 denotes virus
T323 15256-15268 CL:0000784 denotes plasmacytoid
T324 15269-15278 GO:0030425 denotes dendritic
T325 15290-15295 NCBITaxon:10088 denotes mouse
T326 15305-15316 NCBITaxon:11118 denotes coronavirus
T327 15353-15363 CL:0000235;GO:0042116 denotes macrophage
T328 15364-15374 GO:0042116 denotes activation
T329 15414-15419 PR:000001829 denotes CD200
T330 15420-15427 PR:000005161 denotes CD200R1
T331 15452-15463 NCBITaxon:11118 denotes coronavirus
T332 15496-15510 GO:0032607 denotes IFN production
T333 15526-15531 NCBITaxon:10239 denotes virus
T334 15543-15553 GO:0000075 denotes Checkpoint
T335 15554-15564 CHEBI:35222;CHEBI:35222 denotes inhibitors
T336 15688-15693 SP_6;NCBITaxon:9606 denotes human
T337 15769-15775 NCBITaxon:39107 denotes murine
T338 15785-15789 NCBITaxon:10359 denotes LCMV
T339 15803-15808 PR:000001829 denotes CD200
T340 15909-15917 GO:0042571 denotes antibody
T341 15931-15936 PR:000001829 denotes CD200
T342 15974-15979 SP_6;NCBITaxon:9606 denotes human
T343 16063-16073 GO:0000075 denotes checkpoint
T344 16074-16084 CHEBI:35222;CHEBI:35222 denotes inhibitors
T345 16106-16114 SP_7 denotes CoViD-19
T346 16137-16147 GO:0000075 denotes checkpoint
T347 16148-16157 CHEBI:35222;CHEBI:35222 denotes inhibitor
T348 16164-16167 PR:000001919 denotes PD1
T349 16188-16196 SP_7 denotes CoViD-19
T350 16255-16263 SP_7 denotes CoViD-19
T351 16300-16309 SP_7 denotes SARS-CoV2
T352 16376-16389 NCBITaxon:11118 denotes coronaviruses
T353 16561-16568 GO:0007612 denotes learned
T354 16662-16670 SP_10 denotes SARS-CoV
T355 16675-16684 SP_7 denotes SARS-CoV2
T356 16702-16709 GO:0007612 denotes learned
T357 17214-17222 SP_7 denotes CoViD-19
T358 17332-17349 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T359 17568-17586 CHEBI:35705;CHEBI:35705 denotes immunosuppressants
T360 17600-17615 CHEBI:24261;CHEBI:24261 denotes glucocorticoids
T361 17676-17684 SP_7 denotes CoViD-19
T362 17804-17811 GO:0065007 denotes control
T376 18141-18149 SP_7 denotes CoViD-19
T378 18252-18253 UBERON:0002369 denotes n
T379 18373-18390 CHEBI:35705;CHEBI:35705 denotes is encouraged. 3-
T382 18682-18684 DG_35 denotes ou
T383 18689-18696 DG_41 denotes as they
T384 18727-18735 SP_7 denotes CoViD-19
T387 18842-18846 CHEBI:5801;DG_20;CHEBI:5801 denotes logi
T394 18890-18892 SP_7 denotes as
T396 18894-18895 UBERON:0002405;GO:0006955 denotes u
T398 18923-18924 SP_7 denotes v
T400 19049-19055 NCBITaxon:9606 denotes person
T401 19059-19065 NCBITaxon:9606 denotes person
T58617 20-31 NCBITaxon:11118 denotes coronavirus
T98146 108-119 NCBITaxon:11118 denotes Coronavirus
T72856 184-192 SP_7 denotes CoViD-19
T2260 221-224 SP_2 denotes bat
T47192 238-249 NCBITaxon:11118 denotes coronavirus
T57902 257-266 SP_7 denotes SARS-CoV2
T96544 278-286 SO:0000853 denotes homology
T94014 292-296 SP_10 denotes SARS
T32537 301-309 SP_9 denotes MERS-CoV
T49937 371-380 SP_7 denotes SARS-CoV2
T33734 485-496 UBERON:0001004 denotes respiratory
T88595 529-540 UBERON:0001004 denotes respiratory
T80385 657-668 NCBITaxon:11118 denotes coronavirus
T26979 754-759 CHEBI:36044;CHEBI:36044 denotes drugs
T41238 899-907 SP_7 denotes CoViD-19
T84930 934-939 CHEBI:67079;CHEBI:67079 denotes anti-
T650 949-954 CHEBI:23888;CHEBI:23888 denotes drugs
T79379 1017-1021 GO:0006955 denotes host
T95849 1022-1028 UBERON:0002405;GO:0006955 denotes immune
T6514 1029-1037 GO:0006955 denotes response
T18505 1039-1051 CHEBI:38068;CHEBI:38068 denotes Antimalarial
T32081 1052-1057 CHEBI:23888;CHEBI:23888 denotes drugs
T539 1104-1113 GO:0005764 denotes lysosomal
T73496 1142-1147 NCBITaxon:10239;GO:0035376 denotes viral
T3300 1148-1158 GO:0035376 denotes entry into
T95970 1246-1250 PR:000001393 denotes IL-6
T31356 1316-1327 DG_35 denotes tocilizumab
T83133 1371-1382 CHEBI:3213;DG_41;CHEBI:3213 denotes Baricitinib
T98678 1436-1447 GO:0000075 denotes Checkpoints
T65223 1448-1458 CHEBI:35222;CHEBI:35222 denotes inhibitors
T13674 1472-1477 PR:000001829 denotes CD200
T28201 1487-1490 PR:000001919 denotes PD1
T86848 1529-1537 SP_7 denotes CoViD-19
T54496 1573-1590 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T89755 1591-1596 CHEBI:23888;CHEBI:23888 denotes drugs
T3568 1710-1728 CHEBI:35705;CHEBI:35705 denotes immunosuppressants
T80958 1850-1858 SP_7 denotes CoViD-19
T30579 1875-1883 SP_7 denotes CoViD-19
T51687 1908-1917 SP_7 denotes SARS-CoV2
T6303 1942-1953 UBERON:0001004 denotes respiratory
T72752 1976-1988 CHEBI:38068;CHEBI:38068 denotes Antimalarial
T48780 1989-1994 CHEBI:23888;CHEBI:23888 denotes drugs
T785 2015-2019 PR:000001393 denotes IL-6
T55923 2088-2096 SP_7 denotes CoViD-19
T48 8700-8712 CHEBI:38068;CHEBI:38068 denotes antimalaria
T49 8713-8718 CHEBI:23888;CHEBI:23888 denotes drug
T374 21934-21940 NCBITaxon:9606 denotes person
T375 21944-21950 NCBITaxon:9606 denotes person
T44356 19061-19069 SP_7 denotes rson rel
T377 19138-19152 CHEBI:24261;CHEBI:24261 denotes glucocorticoid
T29806 19292-19299 UBERON:0002369 denotes adrenal
T96815 19448-19465 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T380 19651-19659 SP_7 denotes CoViD-19
T381 19766-19772 NCBITaxon:9606 denotes people
T6187 19912-19923 DG_35 denotes tocilizumab
T16477 19928-19939 DG_41 denotes baricitinib
T73916 19970-19978 SP_7 denotes CoViD-19
T385 20101-20110 CHEBI:36357;CHEBI:36357 denotes compounds
T386 20256-20273 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T87903 20355-20373 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T388 20416-20424 SP_7 denotes CoViD-19
T389 20572-20576 PR:000001393 denotes IL-6
T390 20605-20615 CHEBI:35222;CHEBI:35222 denotes inhibitors
T391 20656-20660 UBERON:0002048 denotes lung
T392 20729-20735 CHEBI:52217;CHEBI:52217 denotes agents
T393 20771-20776 NCBITaxon:10239 denotes viral
T50286 20823-20832 SP_7 denotes SARS-CoV2
T395 20840-20844 UBERON:0002048 denotes lung
T84189 20870-20876 UBERON:0002405;GO:0006955 denotes immune
T397 20877-20885 GO:0006955 denotes response
T7725 21109-21117 SP_7 denotes CoViD-19
T399 21610-21618 SP_7 denotes CoViD-19
T13421 21934-21940 NCBITaxon:9606 denotes person
T12638 21944-21950 NCBITaxon:9606 denotes person

2_test

Id Subject Object Predicate Lexical cue
32253068-32113704-55639817 6510-6511 32113704 denotes [
32253068-17243893-55639818 7309-7310 17243893 denotes [
32253068-30258004-55639819 7455-7456 30258004 denotes [
32253068-32150618-55639820 8314-8315 32150618 denotes [
32253068-28466096-55639821 10192-10194 28466096 denotes [1
32253068-19004938-55639822 10195-10197 19004938 denotes ,1
32253068-32143990-55639823 11574-11576 32143990 denotes [1
32253068-28466096-55639824 12847-12849 28466096 denotes [1
32253068-17243893-55639825 13143-13144 17243893 denotes [
32253068-26867177-55639826 13428-13430 26867177 denotes [1
32253068-29172107-55639827 13431-13433 29172107 denotes ,1
32253068-17537853-55639828 13607-13609 17537853 denotes [1
32253068-26867177-55639829 14189-14191 26867177 denotes [1
32253068-29172107-55639830 14639-14641 29172107 denotes [1
32253068-24388216-55639831 15168-15170 24388216 denotes [1
32253068-24388216-55639832 15474-15476 24388216 denotes [1
32253068-24388216-55639833 15987-15989 24388216 denotes [1
32253068-32143990-55639834 17058-17060 32143990 denotes [1
32253068-30789850-55639835 18072-18074 30789850 denotes [2